📰 Induction Study News
Page 2 - Induction Study News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Induction Study. Real-time updates on events, politics, business and more.
February 27, 2023
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the company will attend the annual congress of the European Crohns and Colitis...
February 14, 2023
STOCKHOLM, Feb. 14, 2023 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) is today making a presentation with CEO Jenny Sundqvist available in light of the press release issued January
October 24, 2022
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 2b QUASAR Induction Study 1 in adults with...
October 6, 2022
Five presentations demonstrate Galapagos' commitment to inflammation and the ulcerative colitis (UC) communityNew analyses will be presented from the SELECTION data set on prediction of response and remission
October 6, 2022
Investegate announcements from Galapagos NV, Galapagos provides further insights into the treatment of ulcerative colitis at the upcoming United European Gastroenterology (UEG) Week 2022 congress
February 2, 2022
Nine presentations demonstrate Galapagos' commitment to inflammation and the ulcerative colitis (UC) communityFour new analyses from Phase 3 SELECTION and SELECTION long term extension studies of Jyseleca
October 5, 2021
Investegate announcements from Galapagos NV, Galapagos presents new data from the SELECTION Phase 3 program at the United European Gastroenterology Week (UEGW) 2021 congress
June 4, 2021
Mechelen, Belgium; 4 June 2021; 07.01 CET; - Galapagos NV (Euronext & Nasdaq: GLPG) today announced that primary and secondary endpoint results from the phase 3 SELECTION induction